/images/ppid_59c68470-image-177545756557632439.webp)
What is the story about?
Trump extends Iran deal deadline to Tuesday, otherwise Tehran will be 'living in hell', embassies mock
US President Donald Trump has extended the deadline for Iran to reach a deal over the reopening of the Strait of Hormuz until the evening of Tuesday, April 7, warning that Tehran will face devastating consequences if it fails to comply.
In a series of posts on his social media platform Truth Social, Trump issued stark warnings that the United States could target key Iranian infrastructure if maritime traffic through the strategic waterway is not restored.
US, Iran and mediators make push for 45-day ceasefire, Axios reports
The US, Iran, and a group of regional mediators are discussing the terms for a potential 45-day ceasefire that could lead to a permanent end to the war, Axios reported on Sunday (April 5),
citing four US, Israeli and regional sources with knowledge of the talks.
Reuters could not immediately verify the report. The White House and the US State Department did not immediately respond to Reuters' requests for comment.
Rupee may end the year near current levels, says BofA
The Indian rupee could end the year close to its current levels, with much of its recent depreciation already behind it, according to Bank of America (BofA). Speaking in an interview, Amish Shah, head of India research at BofA, said the bank’s internal foreign exchange view sees the rupee ending the year around 93 per US dollar, broadly in line with prevailing levels.
Indian refiners are selling fuel at ₹60 below cost
A pricing shift in India’s fuel market is pushing oil marketing companies to sell fuel below cost to shield consumers from global price spikes. Refiners are offering discounts of up to ₹60 per litre, putting pressure on margins—especially for standalone players like MRPL and Chennai Petroleum. While there is no formal order, the move is already weighing on stocks, with private refiners taking the biggest hit.
Although fuel is deregulated in India, the upcoming elections in five states may play a role in state-owned refiners' decision to sell below cost.
Why HDFC Bank analysts remain optimistic on the stock touching ₹1,200 levels
Most analysts with coverage on HDFC Bank continue to retain their "buy" recommendation on the stock after the lender reported its fourth-quarter business update over the long weekend. The analysts see targets of as high as ₹1,200 on India's largest private lender, which implies an upside potential of as high as 60% from current levels.
We asked a hedge fund manager to explain Thursday's spike in Indian stocks. Here's what he said.
An unexpected spurt of over 500 points in the Nifty 50 in the second half of trade, combined with a similar spike in the banking stocks, has fizzled out at the start of the new week. For the Nifty 50, holding on to the 22,700-22,800 levels is key to a move back to 23,000.
However, there's no convincing answer to what triggered the sudden recovery in Indian stocks on Thursday. CNBC-TV18 spoke to Conrad Saldanha, Managing Director and Portfolio Manager at Neuberger Berman, which manages over $563 billion in assets under management, according to its website.
These are edited excerpts from the interview.
HDFC Bank to cut rewards from May; link lounge access to spends from July on select credit cards
HDFC Bank is set to roll out a series of changes to its Regalia Gold and Diners Privilege credit cards in the coming months, tightening some existing benefits while introducing new travel-linked features. The revisions, effective May 15 and July 1, signal a shift toward more spend-driven rewards and conditional perks.
Silver just had its worst month in 15 years. Where investors see it going next
Silver, alongside gold, has long been a safe haven for investors during tumultuous times. In March, that script was flipped on its head.
The precious metal ended March 19.7% lower – its largest monthly loss basis since September 2011, when it plunged 28%. March also marked the asset's first month in the red since April 2025.
India’s data centre boom is hitting an invisible ceiling
Data centres are mushrooming in India, at an unprecedented scale and speed, driven by a cost advantage and optimism about the impending demand from accelerating digitisation and artificial intelligence (AI). Yet, beneath this momentum lies a growing tension.
The emerging constraint is no longer capital or intent, but infrastructure readiness.
Banks in FY26: Down, but not out
FY26 was a year of sharp contrasts for Indian financials. Banks stumbled on earnings growth, weighed down by margin compression and credit stress. Yet, investors cheered as select BFSI stocks soared.The sector now braces for a cautious recovery as earnings gradually stabilise.
AI will now make your medicines too: Big Pharma’s $2.75 billion bet on algorithms over laboratories
The idea that artificial intelligence could disrupt white-collar work is no longer new. It has already reshaped industries from algorithmic trading on Wall Street to content creation in Hollywood. And now it’s coming for one of the most complex and high-stakes domains of all - drug discovery.
In a deal that could redefine how medicines are created, Eli Lilly has struck a partnership worth up to $2.75 billion with AI biotech firm Insilico Medicine, signalling thatBig Pharma is no longer experimenting with AI, but it is betting billions on it.
US President Donald Trump has extended the deadline for Iran to reach a deal over the reopening of the Strait of Hormuz until the evening of Tuesday, April 7, warning that Tehran will face devastating consequences if it fails to comply.
In a series of posts on his social media platform Truth Social, Trump issued stark warnings that the United States could target key Iranian infrastructure if maritime traffic through the strategic waterway is not restored.
US, Iran and mediators make push for 45-day ceasefire, Axios reports
The US, Iran, and a group of regional mediators are discussing the terms for a potential 45-day ceasefire that could lead to a permanent end to the war, Axios reported on Sunday (April 5),
Reuters could not immediately verify the report. The White House and the US State Department did not immediately respond to Reuters' requests for comment.
Rupee may end the year near current levels, says BofA
The Indian rupee could end the year close to its current levels, with much of its recent depreciation already behind it, according to Bank of America (BofA). Speaking in an interview, Amish Shah, head of India research at BofA, said the bank’s internal foreign exchange view sees the rupee ending the year around 93 per US dollar, broadly in line with prevailing levels.
Indian refiners are selling fuel at ₹60 below cost
A pricing shift in India’s fuel market is pushing oil marketing companies to sell fuel below cost to shield consumers from global price spikes. Refiners are offering discounts of up to ₹60 per litre, putting pressure on margins—especially for standalone players like MRPL and Chennai Petroleum. While there is no formal order, the move is already weighing on stocks, with private refiners taking the biggest hit.
Why HDFC Bank analysts remain optimistic on the stock touching ₹1,200 levels
Most analysts with coverage on HDFC Bank continue to retain their "buy" recommendation on the stock after the lender reported its fourth-quarter business update over the long weekend. The analysts see targets of as high as ₹1,200 on India's largest private lender, which implies an upside potential of as high as 60% from current levels.
We asked a hedge fund manager to explain Thursday's spike in Indian stocks. Here's what he said.
An unexpected spurt of over 500 points in the Nifty 50 in the second half of trade, combined with a similar spike in the banking stocks, has fizzled out at the start of the new week. For the Nifty 50, holding on to the 22,700-22,800 levels is key to a move back to 23,000.
However, there's no convincing answer to what triggered the sudden recovery in Indian stocks on Thursday. CNBC-TV18 spoke to Conrad Saldanha, Managing Director and Portfolio Manager at Neuberger Berman, which manages over $563 billion in assets under management, according to its website.
These are edited excerpts from the interview.
HDFC Bank to cut rewards from May; link lounge access to spends from July on select credit cards
HDFC Bank is set to roll out a series of changes to its Regalia Gold and Diners Privilege credit cards in the coming months, tightening some existing benefits while introducing new travel-linked features. The revisions, effective May 15 and July 1, signal a shift toward more spend-driven rewards and conditional perks.
Silver just had its worst month in 15 years. Where investors see it going next
Silver, alongside gold, has long been a safe haven for investors during tumultuous times. In March, that script was flipped on its head.
The precious metal ended March 19.7% lower – its largest monthly loss basis since September 2011, when it plunged 28%. March also marked the asset's first month in the red since April 2025.
India’s data centre boom is hitting an invisible ceiling
Data centres are mushrooming in India, at an unprecedented scale and speed, driven by a cost advantage and optimism about the impending demand from accelerating digitisation and artificial intelligence (AI). Yet, beneath this momentum lies a growing tension.
The emerging constraint is no longer capital or intent, but infrastructure readiness.
Banks in FY26: Down, but not out
FY26 was a year of sharp contrasts for Indian financials. Banks stumbled on earnings growth, weighed down by margin compression and credit stress. Yet, investors cheered as select BFSI stocks soared.The sector now braces for a cautious recovery as earnings gradually stabilise.
AI will now make your medicines too: Big Pharma’s $2.75 billion bet on algorithms over laboratories
The idea that artificial intelligence could disrupt white-collar work is no longer new. It has already reshaped industries from algorithmic trading on Wall Street to content creation in Hollywood. And now it’s coming for one of the most complex and high-stakes domains of all - drug discovery.
In a deal that could redefine how medicines are created, Eli Lilly has struck a partnership worth up to $2.75 billion with AI biotech firm Insilico Medicine, signalling thatBig Pharma is no longer experimenting with AI, but it is betting billions on it.
/images/ppid_59c68470-image-177545004339584960.webp)
/images/ppid_59c68470-image-177544006038224316.webp)
/images/ppid_a911dc6a-image-177542043321115967.webp)
